HOPE4OA
Live / Applied — Statement of use — processing complete, to examiner (as of 19 Jul 2025)
What this means for you
Not registered yet, but its 16 Mar 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97841970
- Mark type
- Design + words
- Filed
- 16 Mar 2023
- Published for opposition
- 30 Jan 2024
- Attorney of record
- John Pickerill
Goods and services
- Class 042 — Scientific and technological services: Clinical trials in relation to osteoarthritis; research and development of pharmaceuticals and medicinal preparations and substances for treatment of osteoarthritis
- Class 044 — Medical, beauty and agricultural services: Provision of information in relation to osteoarthritis; providing medical and health care information via a website in relation to osteoarthritis
Owner
- Paradigm BioPharmaceuticals Limited, Melbourne, Victoria, AU
- Paradigm BioPharmaceuticals Limited, Melbourne, Victoria, AU
Prosecution history
- 19 Jul 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Apr 2025 — USE AMENDMENT FILED
- 19 Jul 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Apr 2025 — TEAS STATEMENT OF USE RECEIVED
- 27 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Mar 2025 — SOU EXTENSION 2 GRANTED
- 26 Mar 2025 — SOU EXTENSION 2 FILED
- 26 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Sept 2024 — SOU EXTENSION 1 GRANTED
- 24 Sept 2024 — SOU EXTENSION 1 FILED
- 24 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 26 Mar 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Jan 2024 — PUBLISHED FOR OPPOSITION